Status:

UNKNOWN

Alleviating Stress by Mobile Application' for Depression

Lead Sponsor:

Korea University Guro Hospital

Collaborating Sponsors:

Ministry of Trade, Industry & Energy, Republic of Korea

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

19-65 years

Phase:

NA

Brief Summary

This study is a single-blind, multicenter, randomized, controlled crossover trial. The App, developed in South Korea, is an application that provides integrated interventions for stress reduction for ...

Detailed Description

This study is a single-blind, multicenter, randomized, controlled crossover trial. All subjects who met the inclusion and exclusion criteria will be randomly assigned to the App first group (fAPP) and...

Eligibility Criteria

Inclusion

  • Adults between the ages of 19 and 65;
  • Diagnosed with mild to moderate major depressive disorders in an expert interview evaluation according to the DSM-IV diagnostic criteria (Score of 7-24 on the Hamilton Rating Scale for Depression \[HAM-D\]);
  • Stable medication for 28 days prior to study participation;
  • Informed consent and voluntary participation.

Exclusion

  • Hard to use smart phone or unable to independently use Application;
  • Diagnosed with severe major depressive disorder in an expert interview evaluation according to the DSM-5 diagnostic criteria (score of 25 or more on HAM-D);
  • Severe mental disorders (current or in the past), including Major depressive disorder with psychotic features, bipolar affective disorder, personality disorder, obsessive compulsive disorder, autism spectrum disorder, substance use disorder;
  • History of brain injury, epileptic seizures, intellectual disability, or cognitive disorders;
  • History of severe physical disorders, including cancer, tuberculosis, severe cardiovascular disease, etc.
  • Individuals participating in other cognitive behavioral therapy or activities related to stress relief

Key Trial Info

Start Date :

May 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT05312203

Start Date

May 15 2022

End Date

December 31 2023

Last Update

November 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Psychiatry, Korea University Guro Hospital

Seoul, Guro Gu, South Korea, 08308